Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Patients can search for eligible studies via: NIHR 'Be Part of Research' (www.bepartofresearch.nihr.ac.uk) the recommended UK-facing trial finder ClinicalTrials.gov the international registry listing ongoing Phase 3 and cardiovascular outcome studies of retatrutide EU Clinical Trials Information System (CTIS) for trials registered within the European regulatory framework Clinicians wishing to facilitate trial access should contact their institutional Research and Development (R&D) office
Accessing Retatrutide in Canada Canadian residents interested in Retatrutide have options for accessing this peptide for research purposes
Similarly, discrepant findings are available for activation of the (cardiac) sympathetic nervous system (106, 108111)
The peptide promotes lipolysis without affecting broader growth hormone effects, such as IGF-1 stimulation
Compounded drugs are not FDA-approved or evaluated for safety, effectiveness, or quality by the FDA
I want to see if I can maintain without it. The data on this is not encouraging
